Search Results 31-40 of 26206 for ulcerative colitis
This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP- ...
The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...
The purpose of this study is to evaluate the safety and effectiveness of trichuris suis ova (TSO) in ulcerative colitis (UC). We will look at how TSO ...
A head-to-head comparison suggests that vedolizumab is slightly superior to adalimumab for moderately to severely active ulcerative colitis and should be ...
... ulcerative colitis flares as an adjunct to standard medical treatment. Specifically, we will investigate the impact of hyperbaric oxygen therapy on clinical ...
... colitis, 5,084 (53.5%) were diagnosed with ... ulcerative colitis, with or without concurrent ... IBD are at greater risk of developing CRC than are females with ...
Inflammatory bowel disease (IBD), which consists of Crohn's disease and ulcerative colitis, can be a frustrating diagnosis to deal with. In general, there ...
It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...
Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis · Share · Facebook · Twitter.
... IBD, and irritable bowel syndrome, or IBS ... Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.